IL17A and colorectal cancer: The effect of TNFα, IL-17, and TNFα plus IL-17 on glucose utilization in HT-29 human colorectal cancer cells is shown in Figure 1A. Treatment with TNFα modestly stimulated glucose utilization by the HT-29 cells.